Acromegaly & Prolactinoma (posters)

SUN-100

Long-term somatostatin analog therapy of acromegaly following transsphenoidal surgery: efficacy and safety
Lisa B Nachtigall, Arezoo Haghshenas, Adnan Ajmal, Nicholas A Tritos, Brooke Swearingen, Anne Klibanski and Karen K. Miller

SUN-101

Dose-extension of somatostatin analogues maintains control in acromegaly and saves cost
Viv Thornton-Jones, Alex Vincent, Niki Karavitaki, Ashley B. Grossman and John A. H. Wass

SUN-103

Insulin sensitivity is negatively correlated with the suppression of serum GH level upon oral glucose tolerance test in patients with acromegaly after total removal of pituitary adenoma
Naoki Edo, Koji Morita, Hisanori Suzuki, Akira Takeshita, Noriaki Fukuhara, Hiroshi Nishioka, Yuji Tanaka, Shozo Yamada and Yasuhiro Takeuchi

SUN-104

Frequency of acromegaly in hospitalized patients with type 2 diabetes and its significance
Kentaro Suda, Hidenori Fukuoka, Genzo Iguchi, Naoko Hashimoto, Yushi Hirota, Hironori Bando, Masaaki Yamamoto, Hitoshi Nishizawa, Michiko Takahashi, Kazuhiko Sakaguchi and Yutaka Takahashi

SUN-105

Changes of GH axis after Transsphenoidal Adenomectomy in Acromegalic Patients
Cheol Ryong Ku, Jae Won Hong, Eui Hyun Kim, Sun Ho Kim and Eun Jig Lee

SUN-106

Persistent negative disease perceptions despite long-term biochemical control of acromegaly: novel application of the drawing test
Jitske Tiemensma, Elizabeth Broadbent, Johannes A. Romijn, Alberto M. Pereira, Nienke R. Biermasz and Adrian A Kaptein

SUN-107

Correlation of AcroQoL scores with depression, anxiety, balance and fear of falling measures in acromegalic patients
Aysegul Atmaca, Berna Tander, Elif Kilic Kan, Yasemin Ulus, Gulcin Cengiz Ecemis and Yesim Akyol

SUN-108

Serum Vaspin Levels in Acromegaly Patients
Merve Yilmaz, Arzu Gedik, Can Basaloglu, Dilek Cimrin, Hulya Ellidokuz, Mustafa Secil and Abdurrahman Comlekci

SUN-109

BMI and duration of treatment influence the pegvisomant dose in active acromegaly after long-term follow-up
Antonio Bianchi, Pietro Maffei, Silvia Grottoli, Giorgio Arnaldi, Marta Ragonese, Maria Rosaria Ambrosio, Teresa Porcelli, Antonella Giampietro, Maria Chiara Zatelli, Salvatore Cannavo, Marco Boscaro, Nicola Sicolo, Andrea Giustina, Ezio Ghigo, Alfredo Pontecorvi and Laura De Marinis

SUN-110

The Effect of Somatostatin Analogue Treatment on Thyroid Gland in Acromegaly Patients
Yasemin Tutuncu, Kerim Kucukler, Dilek Berker, Serhat Isik, Gulhan Akbaba, Ufuk Özuguz and Serdar Guler

SUN-111

Factors Affecting Prognosis in a Series of Acromegalic Patients
Francesca Lugli, Alessandra Fusco, Antonio Bianchi, Donato Iacovazzo, Antonella Giampietro, Domenico Milardi, Sabrina Chiloiro, Serena Piacentini, Linda Tartaglione, Francesco Doglietto, Carmelo Anile, Giulio Maira and Laura De Marinis

SUN-112

Thyroid cancer is the most common cancer in patients with acromegaly: a retrospective cohort study in Japanese population at a single center
Naotetsu Kanamoto, Yoriko Ueda, Yui Yamashita, Eri Kondo, Toshihito Fujii, Masako Miura, Akihiro Yasoda, Hiroshi Arai and Kazuwa Nakao

SUN-113

Characteristics of Thyroid lesion in patients with Acromegaly
Jung Soo Lim, Sun Ho Kim and Eun Jig Lee

SUN-115

Assessment of cardiac autonomic functions by heart rate recovery, heart rate variability and QT dynamicity parameters in patients with acromegaly
Muhammet Dural, Giray Kabakci, Nese Cinar, Tomris Erbas, Ugur Canpolat, Murat K Gurses, Lale Tokgozoglu, Ali Oto, Baris E Kaya, Hikmet Yorgun, Levent Sahiner, Selcuk Dagdelen and Kudret Aytemir

SUN-116

Corneal Biomechanical Properties In Patients With Acromegaly
Ahmet Ozkok, Esra Hatipoglu, Burcu Balta, Nevbahar Tamcelik, Ahmet Sadi Gundogdu and Pinar Kadioglu

SUN-118

Is adrenal insufficiency (AI) rare in acromegaly (A) compared with other pituitary adenomas (PA)?
Maria Fleseriu, Nadia Hameed, Christine G Yedinak, Jessica Allison Brzana, Shirley McCartney and Marika Gassner

SUN-119

Clinical, biochemical and radiologic characterization of somatotroph tumors according to adenoma granulation pattern
Carmen A Carrasco, Pablo Villanueva, Roger Gejman, David Rojas Z, Isidro Huete, Romina Zunino, René Diaz, Claudia Tissera and Nelson Wohllk

SUN-121

Silent Somatotroph Adenomas
Veronique Pelletier, France Berthelet, André Lacroix, Isabelle Bourdeau, Catherine Beauregard, Sophie Vallette, Claire Girard and Omar Serri

SUN-122

Disturbed balance and increased fear of falling in acromegalic patients
Aysegul Atmaca, Berna Tander, Elif Kilic Kan, Yasemin Ulus, Gulcin Cengiz Ecemis, Yesim Akyol and Leman Tomak

SUN-123

CHANGES IN Estimated Glomerular Filtration Rate (eGFR) AFTER TRANSSPHENOIDAL SURGERY IN PATIENTS WITH ACROMEGALY
Toko Muraoka, Naomi Hizuka, Izumi Fukuda, Kumiko Asakawa-Yasumoto, Yukiko Ishikawa and Atsuhiro Ichihara

SUN-124

Three dimensional facial analyses in acromegaly: A study to investigate craniofacial characteristics after long-term remission
Sean H.P.P. Roerink, Margreet A.E.M. Wagenmakers, Thomas J.J. Maal, Roel H. Pelleboer, Tong Xi, Johannes W.A. Smit, Stefaan J. Berge, Ad RMM Hermus and Romana T. Netea-Maier

SUN-125

Paradoxical Growth Hormone Response to an Oral Glucose Load – Not always Acromegaly!
Subramanian Kannan, Georgiana Alina Dobri, Leann Olansky and Charles Faiman

SUN-126

What does the GH-producing pituitary adenoma look like at diagnosis on 3.0T MRI and what does it tell us?
Iulia Potorac, Patrick Petrossians, Franck Schillo, Gerald Raverot, François Cotton, Anne Boulin, Stephan Gaillard, Luaba Tshibanda, Albert Beckers and Jean Francois Bonneville

SUN-127

Valvular Heart Disease in Patients with Prolactinomas on Cabergoline Treatment
Diana Arrestia, Lucia Florio, Mauricio Gutierrez, Mariana Elhordoy, Elisa Seoane, Cristina Alonso and Maria Mercedes Pineyro

SUN-128

Serum survivin level in prolactinoma
Fatma Dilek Dellal, Mutlu Niyazoglu, Esranur Ademoglu, Zehra Candan, Suheyla Gorar, Handan Bekdemir, Ziynet alphan Uc, Cavit Culha and Yalcin Aral

SUN-129

Prolactinoma in childrens and adolescents: a retrospective study of presentation, management, and outcomes
Thais P Sickler, Andrea Glezer, Cristina Formiga, Valter Angelo Sperling Cescato, Nina Musolino, Malebranche Cunha Neto and Marcello D Bronstein

SUN-94

The Efficacy of Octreotide LAR in Acromegalic Patients as Primary Therapy
Rafael Loch Batista, Viviane Castelo de Vasconcelos, Ana Paula Cavalcante Normando and Marcos Sergio Neres da Silva

SUN-95

Improvement of Biochemical Control in Patients with Acromegaly Switched from Octreotide LAR to Pasireotide LAR: Crossover Extension to a Double-Blind, Multicenter, Randomized, Phase III Study
Pamela U. Freda, Maria Fleseriu, Aart Jan van der Lely, Annamaria Colao, Michael C Sheppard, Feng Gu, Chiung-Chyi Shen, Monica Gadelha, Andrew J Farrall, Karina Hermosillo Reséndiz, Matthieu Ruffin, YinMiao Chen and Marcello D Bronstein

SUN-96

Efficacy and Safety of Lanreotide in Combination with Pegvisomant in Clinical Practice in Patients with Active Acromegaly with Monotherapy Failure
Eva Venegas, Tomás Lucas, Mónica Marazuela, Guillem Cuatrecasas, María Angeles Galvez, Enrique Romero, Francisco M. Morales-Pérez, Susan M. Webb, Betina Biaggeti, Juan José Diaz, José Antonio Mato, Ricardo Vilchez, Ignacio Bernabeu, Miguel Paja, Antonio Pico, Manuel Puig Domingo, Alfonso Soto and on Behalf Of The ACROCOMB Study Group

SUN-97

Efficacy and safety of lanreotide in combination with cabergoline in clinical practice in patients with active acromegaly
Ricardo Vilchez, Ignacio Bernabeu, Concepción Blanco, Fernando Cordido, Miguel Paja, Rosa Casany, Carmen Fajardo, Silvia Maraver, Tomás Martín, Juan Antonio García Arnes, Pablo Fernández Catalina, María Purificación Martínez de Icaya, Antonio Pico, Gemma Sesmilo, Mónica Marazuela, Alfonso Soto and on Behalf Of The ACROCOMB Study Group

SUN-99

ACROMEGALY TREATMENT WITH OCTREOTIDE LAR IN A ROUTINE CLINICAL CONTEXT: A SINGLE CENTER EXPERIENCE
Ana Laura Espinosa de los Monteros, Baldomero Gonzalez, Guadalupe Vargas, Moises Mercado and Ernesto Sosa